BOOK NOW FOR your podcast
Jonathon Hill
Co-founder & VP of Science and Technology at Wasatch Biolabs
- Scientist
- Professor
- Entrepreneur
- đź“ŤProvo, UT
Dr. Jonathon Hill is the VP of Science and Technology and a co-founder of Wasatch BioLabs, where he leads research and development of proprietary Nanopore sequencing-based technologies with Dr. Timothy Jenkins, VP of Research and Discovery and co-founder.
As an Associate Professor of Cell Biology and Physiology at Brigham Young University with 18 years of experience with genetic and epigenetic research, his research lab combines “bench” biology with bioinformatics and genomic approaches to assemble and determine the underlying mechanics of gene regulatory networks.
read more
 BOOK NOW FOR your podcast
Jonathon Hill
Co-founder & VP of Science and Technology at Wasatch Biolabs
- đź“ŤProvo, UT
- Scientist
- Professor
- Entrepreneur
Dr. Jonathon Hill is the VP of Science and Technology and a co-founder of Wasatch BioLabs, where he leads research and development of proprietary Nanopore sequencing-based technologies with Dr. Timothy Jenkins, VP of Research and Discovery and co-founder.
As an Associate Professor of Cell Biology and Physiology at Brigham Young University with 18 years of experience with genetic and epigenetic research, his research lab combines “bench” biology with bioinformatics and genomic approaches to assemble and determine the underlying mechanics of gene regulatory networks.
read more
As seen on
Timeline
Oct 2022 - Present
Wasatch BioLabs
Co-Founder & VP of Science and Technology
Jun 2015 - Present
Brigham Young University
Associate Professor
Nov 2018 - Present
Pioneer Biolabs
Co-Founder & Scientific Advisor
Dec 2010 - Jun 2016
American Journal Experts
Translator
Sep 2010 - Jun 2015
University of Utah
Postdoctoral Fellow
Jul 2007 - 2010
Columbia University
PhD Student
Ask me
| Tell us about DNA Methylation, what is it and why is it important? |
| Why did WBL make the decision to focus on Oxford Nanopore Technologies sequencing technology? |
| How does your Targeted DNA Methylation Assay compare to array-based methods, or methods such as PacBio? |
| What motivated Wasatch BioLabs to incorporate targeted methylation assays into its sequencing services? How does this capability address unmet needs in clinical and research settings? |
| What potential clinical applications do you foresee for the insights gained from targeted methylation analysis using the PromethION platform, particularly in the context of early diagnostics and personalized medicine where we can tailor treatments and intervention based on individual epigenetic profiles? |
| What role do you see targeted methylation assays playing in advancing our understanding of disease mechanisms and potentially informing therapeutic strategies in the future? |
